Does USTEKINUMAB Cause Intentional dose omission? 66 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Intentional dose omission have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.1% of all adverse event reports for USTEKINUMAB.
66
Reports of Intentional dose omission with USTEKINUMAB
0.1%
of all USTEKINUMAB reports
3
Deaths
20
Hospitalizations
How Dangerous Is Intentional dose omission From USTEKINUMAB?
Of the 66 reports, 3 (4.5%) resulted in death, 20 (30.3%) required hospitalization, and 4 (6.1%) were considered life-threatening.
Is Intentional dose omission Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 66 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Intentional dose omission?
DUPILUMAB (2,269)
CERTOLIZUMAB PEGOL (1,253)
ADALIMUMAB (845)
TOFACITINIB (845)
INFLIXIMAB (815)
ABALOPARATIDE (623)
ETANERCEPT (615)
AMBRISENTAN (595)
SODIUM OXYBATE (580)
CALCIUM OXYBATE\MAGNESIUM OXYBATE\POTASSIUM OXYBATE\SODIUM OXYBATE (518)
Which USTEKINUMAB Alternatives Have Lower Intentional dose omission Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE